| 长春瑞滨联合顺铂治疗晚期非小细胞肺癌160例近期疗效 |
| |
| 引用本文： | 劳逸,陈绍锋,王伟,许德明,蔡永广.长春瑞滨联合顺铂治疗晚期非小细胞肺癌160例近期疗效[J].肿瘤防治研究,2004,31(2):103-104. |
| |
| 作者姓名： | 劳逸 陈绍锋 王伟 许德明 蔡永广 |
| |
| 作者单位： | 524002,广东湛江,广东省农垦中心医院 |
| |
| 摘 要： | 目的 观察长春瑞滨 (NVB)和顺铂 (DDP)联合治疗晚期非小细胞肺癌 (NSCLC)的临床疗效及毒副作用。方法 160例Ⅲb～Ⅳ期初次治疗的非小细胞肺癌 ,用NVB联合DDP(NP方案 )治疗 :NVB2 5mg/m2 ,静滴d1,8,DDP 80mg/m2 静滴d1。结果 有效率 (CR +PR) 55.6% ,中位缓解期 6.2个月。中位生存期 12 .2个月。主要毒副反应为骨髓抑制。结论 NP方案治疗晚期非小细胞肺癌疗效高 ,副反应少 ,病人可耐受 ,值得临床作为一线治疗推广
|
| 关 键 词： | 长春瑞滨 顺铂 非小细胞肺癌 化疗 |
| 文章编号： | 1000-8578(2004)02-0103-02 |
| 收稿时间： | 2003-1-27 |
| 修稿时间： | 2003-4-2 |
Vinorelbine Plus Cisplatin Combination Chemotherapy in Advanced Non-small-cell Lung Cancer |
| |
| LAO Yi,CHEN Shao feng,WANG Wei,et al Central Hospital of GuangDong Province Agricultural Reclamarion,Zhanjiang ,China.Vinorelbine Plus Cisplatin Combination Chemotherapy in Advanced Non-small-cell Lung Cancer[J].Cancer Research on Prevention and Treatment,2004,31(2):103-104. |
| |
| Authors: | LAO Yi CHEN Shao feng WANG Wei Central Hospital of GuangDong Province Agricultural Reclamarion Zhanjiang China |
| |
| Institution: | LAO Yi,CHEN Shao feng,WANG Wei,et al Central Hospital of GuangDong Province Agricultural Reclamarion,Zhanjiang 524002,China |
| |
| Abstract: | Objective To evaluate the efficacy and toxicity of vinorelbine(NVB) plus cisplatin(NP regimen) combination chemotherapy in advanced non small cell lung cancer(NSCLC).Methods A total of 160 patients with advanced non small cell lung cancer were treated by NP regimen: NVB 25 mg/m 2,d 1,8 ; cisplatin 80 mg/m 2,d 1. All of them had stage Ⅲ b～Ⅳ disease, They were primary treatment. Results The overall response rate (RR) was 55.6% ,The median response time 6.2 months. The median survival tim... |
| |
| Keywords: | Vinorelbine Cisplatin Non small cell lung cancer Chemotherapy |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
| 点击此处可从《肿瘤防治研究》浏览原始摘要信息 |
| 点击此处可从《肿瘤防治研究》下载免费的PDF全文 |
|
